LIXTE BIOTECHNOLOGY HLDGS IN's ticker is LIXTW and the CUSIP is 539319111. A total of 4 filers reported holding LIXTE BIOTECHNOLOGY HLDGS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1 | 0.0% | 23,154 | 0.0% | 0.00% | – |
| Q1 2024 | $1 | 0.0% | 23,154 | -0.4% | 0.00% | – |
| Q4 2023 | $1 | -50.0% | 23,254 | 0.0% | 0.00% | – |
| Q3 2023 | $2 | 0.0% | 23,254 | +0.4% | 0.00% | – |
| Q2 2023 | $2 | 0.0% | 23,154 | -0.4% | 0.00% | – |
| Q1 2023 | $2 | -60.0% | 23,254 | -72.7% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 85,311 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -60.0% | 85,311 | +0.1% | 0.00% | – |
| Q2 2022 | $10,000 | – | 85,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 210 | $8 | 0.00% |
| CLEAR STREET LLC | 23,254 | $1 | 0.00% |
| Warberg Asset Management LLC | 40,875 | $1,533 | 0.00% |